Skip to main content
Erschienen in: Gastric Cancer 1/2018

Open Access 01.01.2018 | Review Article

Short-term outcomes in minimally invasive versus open gastrectomy: the differences between East and West. A systematic review of the literature

verfasst von: Nicole van der Wielen, Jennifer Straatman, Miguel A. Cuesta, Freek Daams, Donald L. van der Peet

Erschienen in: Gastric Cancer | Ausgabe 1/2018

Abstract

Objective

Minimally invasive surgical techniques for gastric cancer are gaining more interest worldwide. Several Asian studies have proven the benefits of minimally invasive techniques over the open techniques. Nevertheless, implementation of this technique in Western countries is gradual. The aim of this systematic review is to give insight in the differences in outcomes and patient characteristics in Asian countries in comparison to Western countries.

Methodology

An extensive systematic search was conducted using the Medline, Embase, and Cochrane databases. Analysis of the outcomes was performed regarding operative results, postoperative recovery, complications, mortality, lymph node yield, radicality of the resected specimen, and survival. A total of 12 Asian and 8 Western studies were included.

Results

Minimally invasive gastrectomy shows faster postoperative recovery, fewer complications, and similar outcomes regarding mortality in both the Eastern and Western studies. However, patient characteristics such as age and BMI differ between these populations. Comparison of overall outcomes in minimally invasive and open procedures between East and West showed differences in complications, mortality, and number of resected lymph nodes in favor of the Asian population.

Conclusion

Improved outcomes are observed following minimally invasive gastrectomy in comparison to open procedures in both Western and Asian studies. There are differences in patient characteristics between the Western and Asian populations. Overall outcomes seem to be in favor of the Asian population. These differences may fade with centralization of care for gastric cancer patients in the West and increasing surgical experience.

Introduction

Based on the Japanese gastric cancer treatment guidelines, curative treatment for gastric cancer consists of surgical resection with adequate lymph node dissection. An adequate resection margin of 2 cm is required with T1 tumors, 3 cm for T2 tumors with an expansive growth pattern, and 5 cm for those with infiltrative growth patterns. Additionally, D1 or D1+ lymphadenectomy is indicated for cT1N0 tumors, and D2 is indicated for cN+ or cT2–T4 tumors [1]. Lymph node yield in gastric cancer surgery is strongly associated with survival and therefore considered a marker for quality of care [24]. Since Kitano et al. described the first laparoscopic distal gastrectomy in 1994, the minimally invasive technique has gained increased interest worldwide [5].
Most studies regarding minimally invasive gastrectomy showed good outcomes in countries such as Japan and Korea where there is a relatively high incidence of early gastric cancer because of the screening programs for gastric cancer [6, 7]. There is no screening program for gastric cancer in Western countries and a higher incidence of advanced gastric cancer occurs; thus, the results from Asian studies might not be directly applicable for Western countries. Controversy exists whether postoperative outcomes, radicality, and lymph node yield are influenced by the surgeon’s learning curve, resulting in a slow acceptance and implementation of minimally invasive gastrectomy in the Western world [8].
To compare the outcomes of minimally invasive surgical techniques with open surgical techniques for gastric cancer, several meta-analyses have been conducted in recent years [9, 10].
However, those studies did not differentiate between outcomes in Eastern Asia and the Western world. The aim of this study is to compare the outcomes of the studies conducted in Asia with the studies conducted in the West.

Materials and methods

To identify all relevant publications, a systematic search was performed in the bibliographic databases PubMed, EMBASE.com, and The Cochrane Library (via Wiley) from inception to 24 January 2017. Search terms included controlled terms from MeSH in PubMed, EMtree in EMBASE.com, as well as free text terms. Free text terms were only used in The Cochrane library. Search terms expressing ‘stomach neoplasms’ were used in combination with search terms constituting ‘open surgery’ and ‘laparoscopy.’ The reference list of included articles was hand searched for relevant publications.

Selection criteria

The search findings were independently evaluated for potential eligibility for this meta-analysis by two authors (J.S. and N.W.). The inclusion criteria were (1) the article had to compare minimally invasive gastrectomy with open gastrectomy; (2) only full text articles were included; case reports were not included; (3) the article had to be in English (no other language was accepted); and (4) only gastrectomy for gastric cancer was included. After this selection, another selection based on type of gastrectomy was made. In this systematic review only articles with total or total and subtotal gastrectomies combined were included.

Study characteristics

The Newcastle-Ottawa Quality Assessment Scale (NOS) for retrospective cohort studies and case–control studies was used to assess the quality of the studies. A maximum of nine points could be awarded: four points for selection criteria, two points for comparability, and three points for outcomes. Studies achieving six or more points would be classified as high quality and were used for further analysis. Quality of randomized controlled trials (RCT) was assessed using the Jadad scale for RCT. A maximum of five points could be awarded: two points for adequate randomization, two points for adequate blinding, and one point if all included patients were accounted for.

Definitions

The following definitions were used for the recorded parameters. Regarding operative data: operation duration was defined in minutes (min) and blood loss in milliliters (ml). Hospital stay: time to first flatus and time to first oral intake were reported in days. Definitions of complications varied between different studies: there was no consensus in reporting type or grade of complication such as the Clavien–Dindo grading system for the classification of surgical complications. Therefore, only the frequency of postoperative complications was reported. In-hospital mortality was defined as mortality during hospital stay or within 30 days postoperatively. Proximal and distal resection margins were reported in centimeters.

Statistical analysis

The systematic review was performed in line with the recommendations from the PRISMA statement for reporting systematic reviews and meta-analyses [11]. Review Manager version 5.3.5 (2014) was used for data analyses. Continuous variables were assessed using the weighted mean difference. Dichotomous variables were assessed using the odds ratio. To account for clinical heterogeneity, the random effects model based on DerSimonian and Laird’s method was used [12]. A P value <0.05 was considered statistically significant.
A sub-analysis was made in Review Manager for studies conducted in Asian countries and studies conducted in Western countries. The analyses, performed using Review Manager, only compared the outcomes in the minimally invasive group with the outcomes in the open group. Therefore, calculation of the weighted means per outcome in the Western group and the Eastern group was conducted. Overall weighed means are displayed in Table 1.
Table 1
Overall weighted mean outcomes
 
West
East
MIG
OG
MIG
OG
Age
67.54
68.74
60.70
59.44
BMI
23.97
24.38
22.35
22.69
Blood loss
149.64
397.48
83.52
213.05
Operative time
243.02
233.87
218.81
217.80
First diet
4.41
6.35
4.79
4.85
First flatus
2.90
5.75
3.93
3.96
Hospital stay
9.74
11.22
13.66
14.85
Complications (%)
21.69
30.80
12.23
15.79
Mortality (%)
3.27
5.81
0.33
0.24
Lymph nodes
22.96
18.88
31.29
32.35
MIG minimally invasive gastrectomy, OG open gastrectomy, BMI body mass index

Results

Study selection

The initial literature search resulted in 2182 hits. After deleting duplicate articles, 1429 articles remained suitable for analysis. After selection on title and abstract, 181 articles remained that met the criteria. Sixty articles did not meet the criteria and were not suitable for analysis after reading the full text. Thus, 121 suitable articles were left. After assessing type of gastrectomy and the quality of the study, using the Newcastle Ottawa quality assessment scale for cohort studies and the Jadad scale for randomized controlled trials, a total of 20 studies were included, 19 retrospective studies and 1 randomized controlled trial (RCT) [1332]. Twelve studies were conducted in Asian countries; 8 studies were conducted in Western countries. An overview of the selected articles and patient characteristics is depicted in Tables 2 and 3.
Table 2
Newcastle Ottawa Quality Assessment Scale and Jadad score
References
Representatives of the exposed cohort
Selection of the nonexposed cohort
Ascertainment of exposure
Demonstration that outcome of interest was not present at start of study
Comparability of cohorts (max. 2 points)
Assessment of outcome
Follow-up long enough for outcome of interest
Adequacy of follow-up
Total
Cianchi [25]
1
1
1
1
2
1
1
1
9
Dulucq [26]
1
0
1
1
2
1
1
1
8
Ecker [27]
1
1
1
1
2
1
0
0
7
Guzman [28]
1
0
1
1
1
1
1
1
7
Pugliese [29]
1
0
1
1
1
1
1
1
7
Ramagem [30]
1
1
1
1
1
1
0
0
6
Siani [31]
0
1
0
1
2
1
1
1
7
Topal [32]
1
1
1
1
1
1
1
1
8
An [13]
1
1
1
1
2
1
1
1
9
Du [14]
0
1
1
1
2
0
1
1
7
Jeong [15]
1
1
1
1
1
1
1
1
8
Kawamura [16]
0
1
1
1
2
1
0
0
6
Kim [17]
0
1
1
1
2
0
1
1
7
Kim [18]
1
1
1
1
2
1
1
1
9
Lin [19]
1
1
1
1
1
1
1
1
8
Mochiki [20]
0
1
1
1
1
0
1
1
6
Sakuramoto [21]
0
1
1
1
1
0
1
1
6
Son [22]
0
1
1
1
2
1
1
1
8
Usui [23]
0
0
1
1
2
0
1
1
6
References
Randomization
mentioned
Randomization appropriate
Blinding mentioned
Blinding appropriate
All patients accounted for
Total
Cui [24]
1
1
1
1
1
5
Table 3
Patient characteristics
References
Study period
Design
Country
Sample size
Mean age
Sex M/F
BMI
Tumor stage (%)
Lymph node dissection
MIG
OG
MIG
OG
MIG
OG
MIG
OG
I
II
III
IV
 
Cianchi [25]
06/2008 01/2012
Retrospective
Italy
41
41
  
24/17
25/16
  
28
18
54
0
D1+ α/β/D2
Dulucq [26]
04/1995 03/2004
Retrospective
France
8
11
75 ± 8
67 ± 14
3/5
5/6
      
D1+ β
Ecker [27]
01/1998 12/2011
Retrospective
USA
331
2303
68.85 ± 12.11
69.08 ± 13.01
204/127
1342/961
  
14.8
37.1
47.4
0
 
Guzman [28]
11/1999 01/2009
Retrospective
USA
30
48
70
67
17/13
31/17
24.7
25.6
44.9
33.3
10.3
11.5
D1/D2
Pugliese [29]
06/2000 06/2005
Retrospective
Italy
48
99
      
85.4
6.3
8.3
0
D1+/D2
Ramagem [30]
08/2009 04/2013
Retrospective
Brazil
47
64
57.8 ± 10.53
59.7 ± 11.65
34/13
43/21
23.2 ± 4.36
23.8 ± 4.04
31.5
26.1
42.4
0
D2
Siani [31]
01/2003 10/2009
Matched cohort
Italy
25
25
65 ± 8.5
66 ± 7.8
15/10
18/7
  
20
20
60
0
 
Topal [32]
01/2003 12/2006
Retrospective
Belgium
38
22
66.3 ± 12.3
66.9 ± 14.6
23/15
17/5
24.3 ± 2.8
23.4 ± 4.1
40
23.3
26.7
10
D2
An [13]
2003–2007
Retrospective
Korea
42
162
57.0 ± 11.6
56.6 ± 12.0
23/19
108/54
      
D1+ β/D2
Du [14]
11/2005 05/2009
Retrospective
China
82
94
60.4 ± 18.5
57.8 ± 17.2
54/28
61/33
22.3 ± 2.6
22.5 ± 2.4
5.1
38.1
56.8
0
D2
Cui [24]
10/2010 09/2012
RCT
China
128
142
60.1 ± 12.6
57.5 ± 11.2
88/40
98/44
23.03 ± 3.61
23.66 ± 3.23
21.8
26.7
51.5
0
D2
Jeong [15]
01/2005 12/2007
Retrospective
Korea
261
137
      
69.3
12.8
13.6
4.3
 
Kawamura [16]
01/2003 12/2008
Retrospective
Japan
42
30
63.6 ± 10
64.9 ± 10.5
32/10
21/9
22.7 ± 3.1
22.7 ± 2.9
100
0
0
0
D2
Kim [17]
01/2004 07/2006
Retrospective
Korea
27
33
57.3 ± 14.2
61.6 ± 9.2
16/11
23/10
22.6 ± 3.1
22.4 ± 2.1
    
D1+ α/β/D2
Kim [18]
01/2009 04/2010
Retrospective
Korea
63
127
55.9 ± 12.2
57.3 ± 11.1
43/20
81/46
22.7 ± 2.5
23.0 ± 2.9
    
D2
Lin [19]
01/2005 10/2013
Retrospective
China
2041
1539
61.0 ± 11.1
59.8 ± 10.8
1523/518
1170/369
22.3 ± 3.2
22.6 ± 3.5
26.6
19.9
53.6
0
D1+ α/β/D2
Mochiki [20]
04/1998 12/2007
Retrospective
Japan
20
18
66 ± 2.4
63 ± 2.2
16/4
16/2
  
92.1
2.6
5.3
0
D1+ β
Sakuramoto [21]
07/2003 07/2007
Retrospective
Japan
30
44
63.7 ± 9.2
67.2 ± 9.9
12/18
10/34
21.9 ± 2.7
22.5 ± 3.6
54
25.7
20.3
0
D1+ β/D2
Son [22]
05/2003 12/2009
Retrospective
Korea
39
22
50.7 ± 14
52.4 ± 12.9
13/26
10/12
  
0
32.8
67.2
0
D1+/D2
Usui [23]
05/2011 08/2004
Retrospective
Japan
20
19
66.0 ± 10.4
66.2 ± 10.2
13/7
14/5
21.3 ± 3.1
22.1 ± 2.4
92.3
7.7
0
0
 

Operative results

Operation duration was shorter in the open group in both the Western studies and the Asian studies. The overall results of both subgroups showed a significant difference. Overall weighted mean difference was 30.84 min (95% CI, 8.12–64.81).
Blood loss was significantly less in the minimally invasive group. Overall weighted mean difference was −173.09 ml (95% CI, −216.74 to −129.43). Forest plots of operation duration and blood loss are depicted in Fig. 1.

Postoperative recovery

Hospital stay was significantly shorter in the minimally invasive group. Overall weighted mean difference was −3.46 days (95% CI, −4.49 to −1.63).
The time to first flatus showed a significant difference in favor of the minimally invasive group. In the analysis of only the Asian studies this was not significantly different; the overall weighted mean difference was −1.08 days (95% CI, −7.97 to −0.19).
Time to first diet showed a significant difference in favor of the minimally invasive group. Overall weighted mean difference was −1.85 days (95% CI, −3.61 to −0.10).
Forest plots of postoperative recovery are depicted in Fig. 2.

Morbidity and mortality

Fewer complications occurred in the minimally invasive group in comparison to the open group. Analysis of only the Asian studies showed no significant difference between the two groups. However, overall the analysis showed a significant difference with an odds ratio (OR) of 0.73 (95% CI, 0.58–0.92).
No difference in mortality was seen between the two groups, with an odds ratio of 0.77 (95% CI, 0.49–1.23). Forest plots of morbidity and mortality are depicted in Fig. 3.

Oncological outcomes

Significantly more lymph nodes were resected in the minimally invasive group in comparison to the open group, with an overall weighted mean difference of −1.41 lymph nodes (95% CI, −2.64 to −0.17). A forest plot of lymph node yield is depicted in Fig. 4.
Four Asian studies reported radicality; all reported 100% R0 resections [1315, 22, 24]. Seven Western studies reported radicality [2530, 32]. Only one had all R0 resections, all other studies also reported R1 resections; however there were no differences between the open or minimally invasive groups.
Seven Asian studies reported disease-free and/or overall survival [1315, 1922]. Three studies conducted in Western countries reported disease-free and/or overall survival [26, 29, 31].
Follow-up duration differed between studies, making it difficult to compare these results. Only one study, that by Lin et al., reported a significant difference in survival between the two groups. In the overall 3-year disease free survival, a better survival rate was reported for the minimally invasive group. After comparing survival rates according to tumor stage, this difference disappeared.

Discussion

In conclusion, improved outcomes are observed following minimally invasive gastrectomy in comparison to open procedures in both Western and Asian studies.
There are differences in patient characteristics between the Western and Asian populations. Patient characteristics such as age and body mass index (BMI) are higher in the Western population, which may be explained by the fact that the incidence of gastric cancer is higher in Eastern Asia. Several Asian countries have a screening program for gastric cancer. In Japan, population-based screening is recommended for individuals older than 50 years and in Korea for individuals aged 40–75 years, resulting in a lower age of onset compared to the West [7]. A higher BMI in the Western patient group could correspond to an overall higher BMI in the Western population. In the Netherlands more than 50% of the adult population has a BMI of 25 or higher, and approximately 36% had a BMI between 25 and 30 [33]. Mean BMI in gastric cancer patients in 2014 was 25 [34]. With more-advanced disease in gastric cancer in the West, an average normal BMI might reflect a cachectic overweight patient.
Both Western and Asian studies show better short-term outcomes in favor of minimally invasive surgical techniques, with faster postoperative recovery with a significant shorter hospital stay, shorter time to first flatus, and a shorter time to first diet. It should be noted that international implementation of enhanced recovery protocols (ERAS) might influence these results. Perioperative results show significantly less blood loss in the minimally invasive group; however, operation duration was longer. Additionally, fewer postoperative complications and no differences in mortality were reported. All these short-term advantages can be attributed to the less invasive nature of the minimally invasive approach. These outcomes are in accordance with other meta-analyses comparing minimally invasive with open gastrectomies [9, 10].
When comparing East with West, more blood loss and longer operation duration are seen in the Western studies, which may be attributed to the lower overall incidence of gastric cancer in Western countries. Blood loss and operation duration might not have clinical value, but these outcomes could indicate Western surgeons have less experience in the treatment of gastric cancer. Only one study reported on surgeon experience; one experienced surgeon performed all minimally invasive procedures [32]. It should be noted that the incidence of performing minimally invasive gastrectomy was low in the Western studies. In all but one Western study fewer than 10 minimally invasive procedures were performed annually. With a learning curve reported at 20–40 procedures, this finding indicates progression through the learning curve is slow and might affect the presented results [35].
With regard to complications and mortality, these outcomes seem to show a trend in favor of the Asian studies. There are two large studies reporting the outcomes of mortality rate [19, 27]. Analyses with and without these studies did not show an effect on the outcomes presented here. An overall significant difference in lymph node yield in the minimally invasive group was seen, with a mean difference of 1.41 lymph nodes. No effects on clinical outcome are to be expected from this result. More importantly, all studies reported an average of at least 19 resected lymph nodes, which is in accordance with the recommendations of the Japanese Gastric Cancer Association, which advocates removal of at least 15 lymph nodes [1]. The overall differences in lymph node yield show a trend toward a higher number of resected lymph nodes in the Eastern studies, which can be attributed to the greater experience of Asian surgeons with the surgical treatment of gastric cancer. Additionally, pathological examination of lymph nodes can be different, with lymph node dissection taking place separately or en bloc. Furthermore, examination by a specialized upper gastrointestinal pathologist could influence the outcome. Unfortunately, no study reported if lymph node yield was done separately or en bloc.
The difference in survival reported by Lin et al. could be explained by the heterogeneity of both groups, with larger tumors and more advanced disease in the open group [19].
Overall outcomes seem to be in favor of the Asian population. Future research should aim to further assess differences in population, patient assessment, surgical techniques, and experience, to ensure optimal treatment for all gastric cancer patients. In the West care for gastric cancer patients is more and more centralized to specialized treatment units, ensuring optimal care, not only by experienced surgeons, but by an experienced treatment team, ranging from preoperative workup to perioperative care and follow-up. The implementation of minimally invasive techniques for gastric cancer is progressing gradually in Western countries. Several randomized controlled trials are being conducted in the West comparing minimally invasive with open gastrectomy for gastric cancer [36, 37]. These developments may aid in diminishing the differences between the East and West.

Conclusion

Improved outcomes are observed in both Western and Asian studies following minimally invasive gastrectomy in comparison to open procedures. There are differences in patient characteristics between the Western and Asian population. Overall outcomes, such as lymph node yield, complications, and mortality, seem to be in favor of the Asian population. These differences may fade with centralization of care for gastric cancer patients in the West and increasing surgical experience.

Compliance with ethical standards

Human and animal rights

This article does not contain any studies with human or animal subjects performed by any of the authors.

Conflict of interest

The authors declare that they have no conflict of interest.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Anhänge

Appendix

Recent queries
Search
Add to builder
Query
Items found
Time
#5
Add
Search (#4 NOT (“addresses”[Publication Type] OR “biography”[Publication Type] OR “Case Reports” [Publication Type] OR “comment”[Publication Type] OR “directory”[Publication Type] OR “editorial”[Publication Type] OR “festschrift”[Publication Type] OR “interview”[Publication Type] OR “lectures”[Publication Type] OR “legal cases”[Publication Type] OR “legislation”[Publication Type] OR “letter”[Publication Type] OR “news”[Publication Type] OR “newspaper article”[Publication Type] OR “patient education handout”[Publication Type] OR “popular works”[Publication Type] OR “congresses”[Publication Type] OR “consensus development conference”[Publication Type] OR “consensus development conference, nih”[Publication Type] OR “practice guideline”[Publication Type]) NOT (animals[mh] NOT humans[mh)
902
05:45:48
#4
Add
Search (#1 AND #2 AND #3)
1040
05:45:07
#3
Add
Search (“open Surgery”[tiab] OR “open procedure”[tiab] OR “open operation”[tiab] OR laparotomy[tiab] OR laparotomies[tiab] OR open gastrectomy[tiab] OR “open resection”[tiab] OR “open gastric resection”[tiab] OR “open Surgery”[ot] OR “open procedure”[ot] OR “open operation”[ot] OR laparotomy[ot] OR laparotomies[ot] OR “open gastrectomy”[ot] OR “open resection”[ot] OR “open gastric resection”[ot)
59,229
05:44:38
#2
Add
Search (“Surgical Procedures, Minimally Invasive”[Mesh:NoExp] OR “Laparoscopy”[Mesh] OR “Video-Assisted Surgery”[Mesh] OR “gastrectomy”[MeSH] OR Laparoscopy[tiab] OR Laparoscopies[tiab] OR laparoscopic[tiab] OR videolaparoscop*[tiab] OR abdominoscop*[tiab] OR “Video-Assisted”[tiab] OR “Minimal Surgical”[tiab] OR “Minimally Invasive”[tiab] OR “Minimal Invasive”[tiab] OR “Minimal Access Surgical Procedures”[tiab] OR Laparoscopy[ot] OR Laparoscopies[ot] OR laparoscopic[ot] OR videolaparoscop*[ot] OR abdominoscop*[ot] OR “Video-Assisted”[ot] OR “Minimal Surgical”[ot] OR “Minimally Invasive”[ot] OR “Minimally Invasive”[ot] OR “Minimal Access Surgical Procedures”[ot)
189,153
05:44:07
#1
Add
Search (“Stomach Neoplasms”[Mesh] OR Stomach Neoplasm*[tiab] OR Gastric Neoplasm*[tiab] OR Stomach Cancer*[tiab] OR Gastric Cancer*[tiab] OR Stomach carcinoma*[tiab] OR gastric carcinoma*[tiab] OR stomach tumor*[tiab] OR stomach tumour*[tiab] OR gastric tumor*[tiab] OR gastric tumour*[tiab] OR stomach neoplasia*[tiab] OR cardia carcinoma*[tiab] OR linitis plastica[tiab] OR Stomach Neoplasm*[ot] OR Gastric Neoplasm*[ot] OR Stomach Cancer*[ot] OR Gastric Cancer*[ot] OR Stomach carcinoma*[ot] OR gastric carcinoma*[ot] OR stomach tumor*[ot] OR stomach tumour*[ot] OR gastric tumor*[ot] OR gastric tumour*[ot] OR stomach neoplasia*[ot] OR cardia carcinoma*[ot] OR linitis plastica[ot)
99,259
05:43:31
Literatur
1.
Zurück zum Zitat Association Japanese Gastric Cancer. Japanese gastric cancer treatment guidelines 2010 (version 3). Gastric Cancer. 2011;14:113–23.CrossRef Association Japanese Gastric Cancer. Japanese gastric cancer treatment guidelines 2010 (version 3). Gastric Cancer. 2011;14:113–23.CrossRef
2.
Zurück zum Zitat Cutsem EV, Dicato M, Geva R, Arber N, Bang Y, Benson A, et al. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona 2010. Ann Oncol. 2011;22(5):v1–9.CrossRefPubMed Cutsem EV, Dicato M, Geva R, Arber N, Bang Y, Benson A, et al. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona 2010. Ann Oncol. 2011;22(5):v1–9.CrossRefPubMed
3.
Zurück zum Zitat Dikken JL, Stiekema J, van de Velde CJ, Verheij M, Cats A, Wouters MW, et al. Quality of care indicators for the surgical treatment of gastric cancer: a systematic review. Ann Surg Oncol. 2013;20(2):381–98.CrossRefPubMed Dikken JL, Stiekema J, van de Velde CJ, Verheij M, Cats A, Wouters MW, et al. Quality of care indicators for the surgical treatment of gastric cancer: a systematic review. Ann Surg Oncol. 2013;20(2):381–98.CrossRefPubMed
4.
Zurück zum Zitat Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21(19):3647–50.CrossRefPubMed Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21(19):3647–50.CrossRefPubMed
5.
Zurück zum Zitat Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1994;4(2):146–8.PubMed Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1994;4(2):146–8.PubMed
6.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.CrossRefPubMed
7.
Zurück zum Zitat Hamashima C KY, Choi KS. Comparison of guidelines and management for gastric cancer screening between Korea and Japan. ISPOR 20th Annual International Meeting; Philadelphia 2015. Hamashima C KY, Choi KS. Comparison of guidelines and management for gastric cancer screening between Korea and Japan. ISPOR 20th Annual International Meeting; Philadelphia 2015.
8.
9.
Zurück zum Zitat Chen XZ, Wen L, Rui YY, Liu CX, Zhao QC, Zhou ZG, et al. Long-term survival outcomes of laparoscopic versus open gastrectomy for gastric cancer: a systematic review and meta-analysis. Medicine (Baltim). 2015;94(4):e454.CrossRef Chen XZ, Wen L, Rui YY, Liu CX, Zhao QC, Zhou ZG, et al. Long-term survival outcomes of laparoscopic versus open gastrectomy for gastric cancer: a systematic review and meta-analysis. Medicine (Baltim). 2015;94(4):e454.CrossRef
10.
Zurück zum Zitat Straatman J, van der Wielen N, Cuesta MA, de Lange-de Klerk ES, Jansma EP, van der Peet DL. Minimally invasive versus open total gastrectomy for gastric cancer: a systematic review and meta-analysis of short-term outcomes and completeness of resection: surgical techniques in gastric cancer. World J Surg. 2016;40(1):148–57.CrossRefPubMed Straatman J, van der Wielen N, Cuesta MA, de Lange-de Klerk ES, Jansma EP, van der Peet DL. Minimally invasive versus open total gastrectomy for gastric cancer: a systematic review and meta-analysis of short-term outcomes and completeness of resection: surgical techniques in gastric cancer. World J Surg. 2016;40(1):148–57.CrossRefPubMed
11.
Zurück zum Zitat Liberati AAD, Tetzlaff J, Mulrow C, Gøtzsche PC, Loannidis JPA. The PRISM statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1–34.CrossRef Liberati AAD, Tetzlaff J, Mulrow C, Gøtzsche PC, Loannidis JPA. The PRISM statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1–34.CrossRef
12.
Zurück zum Zitat DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.CrossRefPubMed DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.CrossRefPubMed
13.
Zurück zum Zitat An JY, Heo GU, Cheong JH, Hyung WJ, Choi SH, Noh SH. Assessment of open versus laparoscopy-assisted gastrectomy in lymph node-positive early gastric cancer: a retrospective cohort analysis. J Surg Oncol. 2010;102(1):77–81.CrossRefPubMed An JY, Heo GU, Cheong JH, Hyung WJ, Choi SH, Noh SH. Assessment of open versus laparoscopy-assisted gastrectomy in lymph node-positive early gastric cancer: a retrospective cohort analysis. J Surg Oncol. 2010;102(1):77–81.CrossRefPubMed
14.
Zurück zum Zitat Du J, Zheng J, Li Y, Li J, Ji G, Dong G, et al. Laparoscopy-assisted total gastrectomy with extended lymph node resection for advanced gastric cancer: reports of 82 cases. Hepatogastroenterology. 2010;57(104):1589–94.PubMed Du J, Zheng J, Li Y, Li J, Ji G, Dong G, et al. Laparoscopy-assisted total gastrectomy with extended lymph node resection for advanced gastric cancer: reports of 82 cases. Hepatogastroenterology. 2010;57(104):1589–94.PubMed
15.
Zurück zum Zitat Jeong SH, Lee YJ, Park ST, Choi SK, Hong SC, Jung EJ, et al. Risk of recurrence after laparoscopy-assisted radical gastrectomy for gastric cancer performed by a single surgeon. Surg Endos Other Interv Tech. 2011;25(3):872–8.CrossRef Jeong SH, Lee YJ, Park ST, Choi SK, Hong SC, Jung EJ, et al. Risk of recurrence after laparoscopy-assisted radical gastrectomy for gastric cancer performed by a single surgeon. Surg Endos Other Interv Tech. 2011;25(3):872–8.CrossRef
16.
Zurück zum Zitat Kawamura H, Yokota R, Homma S, Kondo Y. Comparison of respiratory function recovery in the early phase after laparoscopy-assisted gastrectomy and open gastrectomy. Sur Endos Other Interv Tech. 2010;24(11):2739–42.CrossRef Kawamura H, Yokota R, Homma S, Kondo Y. Comparison of respiratory function recovery in the early phase after laparoscopy-assisted gastrectomy and open gastrectomy. Sur Endos Other Interv Tech. 2010;24(11):2739–42.CrossRef
17.
Zurück zum Zitat Kim SG, Lee YJ, Ha WS, Jung EJ, Ju YT, Jeong CY, et al. LATG with extracorporeal esophagojejunostomy: is this minimal invasive surgery for gastric cancer? J Laparoendosc Adv Surg Tech Part A. 2008;18(4):572–8.CrossRef Kim SG, Lee YJ, Ha WS, Jung EJ, Ju YT, Jeong CY, et al. LATG with extracorporeal esophagojejunostomy: is this minimal invasive surgery for gastric cancer? J Laparoendosc Adv Surg Tech Part A. 2008;18(4):572–8.CrossRef
18.
Zurück zum Zitat Kim MG, Kim BS, Kim TH, Kim KC, Yook JH, Kim BS. The effects of laparoscopic assisted total gastrectomy on surgical outcomes in the treatment of gastric cancer. J Korean Surg Soc. 2011;80(4):245–50.CrossRefPubMedPubMedCentral Kim MG, Kim BS, Kim TH, Kim KC, Yook JH, Kim BS. The effects of laparoscopic assisted total gastrectomy on surgical outcomes in the treatment of gastric cancer. J Korean Surg Soc. 2011;80(4):245–50.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Lin JX, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, et al. Surgical outcomes of 2041 consecutive laparoscopic gastrectomy procedures for gastric cancer: a large-scale case control study. PLoS One. 2015;10(2):e0114948.CrossRefPubMedPubMedCentral Lin JX, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, et al. Surgical outcomes of 2041 consecutive laparoscopic gastrectomy procedures for gastric cancer: a large-scale case control study. PLoS One. 2015;10(2):e0114948.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Son T, Hyung WJ, Lee JH, Kim YM, Noh SH. Minimally invasive surgery for serosa-positive gastric cancer (pT4a) in patients with preoperative diagnosis of cancer without serosal invasion. Surg Endosc Other Interv Tech. 2014;28(3):866–74.CrossRef Son T, Hyung WJ, Lee JH, Kim YM, Noh SH. Minimally invasive surgery for serosa-positive gastric cancer (pT4a) in patients with preoperative diagnosis of cancer without serosal invasion. Surg Endosc Other Interv Tech. 2014;28(3):866–74.CrossRef
23.
Zurück zum Zitat Usui S, Yoshida T, Ito K, Hiranuma S, Kudo SE, Iwai T. Laparoscopy-assisted total gastrectomy for early gastric cancer: comparison with conventional open total gastrectomy. Surg Laparosc Endosc Percutaneous Tech. 2005;15(6):309–14.CrossRef Usui S, Yoshida T, Ito K, Hiranuma S, Kudo SE, Iwai T. Laparoscopy-assisted total gastrectomy for early gastric cancer: comparison with conventional open total gastrectomy. Surg Laparosc Endosc Percutaneous Tech. 2005;15(6):309–14.CrossRef
24.
Zurück zum Zitat Cui M, Li Z, Xing J, Yao Z, Liu M, Chen L, et al. A prospective randomized clinical trial comparing D2 dissection in laparoscopic and open gastrectomy for gastric cancer. Med Oncol (Northwood). 2015;32(10):241.CrossRef Cui M, Li Z, Xing J, Yao Z, Liu M, Chen L, et al. A prospective randomized clinical trial comparing D2 dissection in laparoscopic and open gastrectomy for gastric cancer. Med Oncol (Northwood). 2015;32(10):241.CrossRef
25.
Zurück zum Zitat Cianchi F, Qirici E, Trallori G, Macrì G, Indennitate G, Ortolani M, et al. Totally laparoscopic versus open gastrectomy for gastric cancer: a matched cohort study. J Laparoendosc Adv Surg Tech. 2013;23(2):117–22.CrossRef Cianchi F, Qirici E, Trallori G, Macrì G, Indennitate G, Ortolani M, et al. Totally laparoscopic versus open gastrectomy for gastric cancer: a matched cohort study. J Laparoendosc Adv Surg Tech. 2013;23(2):117–22.CrossRef
26.
Zurück zum Zitat Dulucq JL, Wintringer P, Stabilini C, Solinas L, Perissat J, Mahajna A. Laparoscopic and open gastric resections for malignant lesions: a prospective comparative study. Surg Endosc. 2005;19(7):933–8.CrossRefPubMed Dulucq JL, Wintringer P, Stabilini C, Solinas L, Perissat J, Mahajna A. Laparoscopic and open gastric resections for malignant lesions: a prospective comparative study. Surg Endosc. 2005;19(7):933–8.CrossRefPubMed
27.
Zurück zum Zitat Ecker BL, Datta J, McMillan MT, Poe SL, Drebin JA, Fraker DL, et al. Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: utilization and short-term oncologic outcomes. J Surg Oncol. 2015;112(6):616–21.CrossRefPubMed Ecker BL, Datta J, McMillan MT, Poe SL, Drebin JA, Fraker DL, et al. Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: utilization and short-term oncologic outcomes. J Surg Oncol. 2015;112(6):616–21.CrossRefPubMed
28.
Zurück zum Zitat Guzman EA, Pigazzi A, Lee B, Soriano PA, Nelson RA, Benjamin Paz I, et al. Totally laparoscopic gastric resection with extended lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol. 2009;16(8):2218–23.CrossRefPubMed Guzman EA, Pigazzi A, Lee B, Soriano PA, Nelson RA, Benjamin Paz I, et al. Totally laparoscopic gastric resection with extended lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol. 2009;16(8):2218–23.CrossRefPubMed
29.
Zurück zum Zitat Pugliese R, Maggioni D, Sansonna F, Scandroglio I, Ferrari GC, Di Lernia S, et al. Total and subtotal laparoscopic gastrectomy for adenocarcinoma. Surg Endosc Other Interv Tech. 2007;21(1):21–7.CrossRef Pugliese R, Maggioni D, Sansonna F, Scandroglio I, Ferrari GC, Di Lernia S, et al. Total and subtotal laparoscopic gastrectomy for adenocarcinoma. Surg Endosc Other Interv Tech. 2007;21(1):21–7.CrossRef
30.
Zurück zum Zitat Ramagem CA, Linhares M, Lacerda CF, Bertulucci PA, Wonrath D, de Oliveira AT. Comparison of laparoscopic total gastrectomy and laparotomic total gastrectomy for gastric cancer. Braz Arch Dig Surg. 2015;28(1):65–9. Ramagem CA, Linhares M, Lacerda CF, Bertulucci PA, Wonrath D, de Oliveira AT. Comparison of laparoscopic total gastrectomy and laparotomic total gastrectomy for gastric cancer. Braz Arch Dig Surg. 2015;28(1):65–9.
31.
Zurück zum Zitat Siani LM, Ferranti F, De Carlo A, Quintiliani A. Completely laparoscopic versus open total gastrectomy in stage I-III/C gastric cancer: safety, efficacy and 5-year oncologic outcome. Minerva Chirurg. 2012;67(4):319–26. Siani LM, Ferranti F, De Carlo A, Quintiliani A. Completely laparoscopic versus open total gastrectomy in stage I-III/C gastric cancer: safety, efficacy and 5-year oncologic outcome. Minerva Chirurg. 2012;67(4):319–26.
35.
Zurück zum Zitat Kim HG, Park JH, Jeong SH, Lee YJ, Ha WS, Choi SK, et al. Totally laparoscopic distal gastrectomy after learning curve completion: comparison with laparoscopy-assisted distal gastrectomy. J Gastric Cancer. 2013;13(1):26–33.CrossRefPubMedPubMedCentral Kim HG, Park JH, Jeong SH, Lee YJ, Ha WS, Choi SK, et al. Totally laparoscopic distal gastrectomy after learning curve completion: comparison with laparoscopy-assisted distal gastrectomy. J Gastric Cancer. 2013;13(1):26–33.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Haverkamp L, Brenkman HJ, Seesing MF, Gisbertz SS, van Berge Henegouwen MI, Luyer MD, et al. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). BMC Cancer. 2015;15:556.CrossRefPubMedPubMedCentral Haverkamp L, Brenkman HJ, Seesing MF, Gisbertz SS, van Berge Henegouwen MI, Luyer MD, et al. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). BMC Cancer. 2015;15:556.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Straatman J, van der Wielen N, Cuesta MA, Gisbertz SS, Hartemink KJ, Alonso Poza A, et al. Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): study protocol for a randomized controlled trial. Trials. 2015;16:123.CrossRefPubMedPubMedCentral Straatman J, van der Wielen N, Cuesta MA, Gisbertz SS, Hartemink KJ, Alonso Poza A, et al. Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): study protocol for a randomized controlled trial. Trials. 2015;16:123.CrossRefPubMedPubMedCentral
Metadaten
Titel
Short-term outcomes in minimally invasive versus open gastrectomy: the differences between East and West. A systematic review of the literature
verfasst von
Nicole van der Wielen
Jennifer Straatman
Miguel A. Cuesta
Freek Daams
Donald L. van der Peet
Publikationsdatum
01.01.2018
Verlag
Springer Japan
Erschienen in
Gastric Cancer / Ausgabe 1/2018
Print ISSN: 1436-3291
Elektronische ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-017-0747-0

Weitere Artikel der Ausgabe 1/2018

Gastric Cancer 1/2018 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.